Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor
Clinical trial NCT02250170 · COMPLETED
Trial details
- NCT number
- NCT02250170
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-23
- Primary completion
- 2019-03-08
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.